Stay updated on Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial

Sign up to get notified when there's something new on the Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The change on the webpage represents an update in the participation criteria from 'Investigators' to 'Researchers' for the study involving post-menopausal females with ER+/HER2- breast cancer. The criteria now include specific details such as histological confirmation, ER and HER2 status requirements, tumor size, performance status, and willingness to undergo specific procedures.
    Difference
    23%
    Check dated 2024-05-22T07:57:55.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change likely indicates an update or revision in the estimated completion date of a medical study related to breast cancer treatment using ARV-471 or anastrozole in post-menopausal women.
    Difference
    0.1%
    Check dated 2024-05-09T02:11:56.000Z thumbnail image
  7. Check
    19 days ago
    Change Detected
    Summary
    The value 01 22 01 19 01 22 has recently changed to 05 07 05 06 (Estimated) 05 07. This change likely represents an update or revision in the estimated study completion date for the Phase 2 neoadjuvant study evaluating ARV-471 or anastrozole in post-menopausal women with ER+/HER2- localized breast cancer.
    Difference
    0.7%
    Check dated 2024-05-07T20:04:58.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:35:28.000Z thumbnail image

Stay in the know with updates to Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial page.